BioCurex, Inc.(fka BOCX)

[JAZZ ONE]

Time to calm down. Lets look at what they did say that might pertain to their interest and investment in BOCX.

Their main emphasis is diagnostics that can be used directly by patients at home and/or doctors at the office. They are concentrating in three major areas: Congestic Heart Failure, Women's Health, and Oncology.

Given that "Point of Care" diagnostics is big for them and they will continue to buy companies time.

They will launch new products for the next 5 years, at least 1 per year.

If you are a IMA investor I'd say this is good news. As for us and BOCX I think they and are looking at what BOCX can do to sure up the Point of Care diagnostics and IMA's oncology work.

Let's hope they are right. They certainly sound like they are very forward thinking and want to lead the market. They certainly know more then we do.